Early atherosclerosis and vascular inflammation in mice with diet-induced type 2 diabetes

European Journal of Clinical Investigation

Volumn 39, Issue 3, 2009, Pages 190-199

  Bartels, E D ^a   Bang, C A ^a   Nielsen, L B ^a,b  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Atherosclerosis; Dyslipidaemia; Obesity; Type 2 diabetes

Indexed keywords

APOLIPOPROTEIN B; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VASCULAR CELL ADHESION MOLECULE 1; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HYPERLIPIDEMIA; LIPID DIET; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; TRANSGENIC MOUSE; VASCULITIS;

ANIMALS; ARTERITIS; ATHEROSCLEROSIS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIETARY FATS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HYPERLIPIDEMIAS; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OBESITY; RANDOM ALLOCATION; RISK FACTORS; STATISTICS AS TOPIC; TIME FACTORS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 61349113418     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02086.x     Document Type: Article

References (32)

1. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002 287 : 2570 81.
2. Fox CS, Pencina MJ, Meigs JB, Vasan RS, Levitzky YS, D'Agostino RB Sr. Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation 2006 113 : 2914 8.
3. Mundy AL, Haas E, Bhattacharya I, Widmer CC, Kretz M, Hofmann-Lehmann R et al. Fat intake modifies vascular responsiveness and receptor expression of vasoconstrictors: implications for diet-induced obesity. Cardiovasc Res 2007 73 : 368 75.
4. Laakso M, Pyorala K. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes. Metabolism 1990 39 : 117 22.
5. McGill HC Jr., McMahan CA, Herderick EE, Zieske AW, Malcom GT, Tracy RE et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002 105 : 2712 8.
6. Baker JL, Olsen LW, Sorensen TI. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 2007 357 : 2329 37.
7. Yang RZ, Lee MJ, Hu H, Pollin TI, Ryan AS, Nicklas BJ et al. Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med 2006 3 : e287.
8. Burnett MS, Lee CW, Kinnaird TD, Stabile E, Durrani S, Dullum MK et al. The potential role of resistin in atherogenesis. Atherosclerosis 2005 182 : 241 8.
9. Bodary PF, Gu S, Shen Y, Hasty AH, Buckler JM, Eitzman DT. Recombinant leptin promotes atherosclerosis and thrombosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2005 25 : e119 22.
10. Nishina PM, Naggert JK, Verstuyft J, Paigen B. Atherosclerosis in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism 1994 43 : 554 8.
11. Yen TT, Allan JA, Pearson DV, Schinitsky MR. Dissociation of obesity, hypercholesterolemia and diabetes from atherosclerosis in ob/ob mice. Experientia 1977 33 : 995 6.
12. Hasty AH, Shimano H, Osuga J, Namatame I, Takahashi A, Yahagi N et al. Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J Biol Chem 2001 276 : 37402 8.
13. Wu KK, Wu TJ, Chin J, Mitnaul LJ, Hernandez M, Cai TQ et al. Increased hypercholesterolemia and atherosclerosis in mice lacking both ApoE and leptin receptor. Atherosclerosis 2005 181 : 251 9.
14. Gruen ML, Saraswathi V, Nuotio-Antar AM, Plummer MR, Coenen KR, Hasty AH. Plasma insulin levels predict atherosclerotic lesion burden in obese hyperlipidemic mice. Atherosclerosis 2006 186 : 54 64.
15. Taleb S, Herbin O it-Oufella H, Verreth W, Gourdy P, Barateau V et al. Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis. Arterioscler Thromb Vasc Biol 2007 27 : 2691 8.
16. Chiba T, Shinozaki S, Nakazawa T, Kawakami A, Ai M, Kaneko E et al. Leptin deficiency suppresses progression of atherosclerosis in apoE-deficient mice. Atherosclerosis 2008 196 : 68 75.
17. Heinonen SE, Leppanen P, Kholova I, Lumivuori H, Hakkinen SK, Bosch F et al. Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia. Circ Res 2007 101 : 1058 67.
18. Schreyer SA, Wilson DL, LeBoeuf RC. C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. Atherosclerosis 1998 136 : 17 24.
19. Linton MF, Farese RV Jr., Chiesa G, Grass DS, Chin P, Hammer RE et al. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J Clin Invest 1993 92 : 3029 37.
20. Callow MJ, Stoltzfus LJ, Lawn RM, Rubin EM. Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice. Proc Natl Acad Sci USA 1994 91 : 2130 4.
21. Berg K, Svindland A, Smith AJ, Lawn RM, Djurovic S, Alestrom A et al. Spontaneous atherosclerosis in the proximal aorta of LPA transgenic mice on a normal diet. Atherosclerosis 2002 163 : 99 104.
22. Bro S, Moeller F, Andersen CB, Olgaard K, Nielsen LB. Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-E-deficient mice. J Am Soc Nephrol 2004 15 : 1495 503.
23. Gruen ML, Plummer MR, Zhang W, Posey KA, Linton MF, Fazio S et al. Persistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-I. J Lipid Res 2005 46 : 2007 14.
24. Goldberg IJ. Why does diabetes increase atherosclerosis? I don't know! J Clin Invest 2004 114 : 613 5.
25. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 1988 37 : 1163 7.
26. Van Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, Desouza CA. Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity 2006 14 : 2127 31.
27. Duvillard L, Pont F, Florentin E, Galland-Jos C, Gambert P, Verges B. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study. Eur J Clin Invest 2000 30 : 685 94.
28. Iribarren C, Sidney S, Sternfeld B, Browner WS. Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA 2000 283 : 2810 5.
29. Shao JS, Cheng SL, Pingsterhaus JM, Charlton-Kachigian N, Loewy AP. Towler DA. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 2005 115 : 1210 20.
30. Towler DA, Bidder M, Latifi T, Coleman T, Semenkovich CF. Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J Biol Chem 1998 273 : 30427 34.
31. Qiao JH, Xie PZ, Fishbein MC, Kreuzer J, Drake TA, Demer LL et al. Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. Arterioscler Thromb 1994 14 : 1480 97.
32. Qiao JH, Fishbein MC, Demer LL, Lusis AJ. Genetic determination of cartilaginous metaplasia in mouse aorta. Arterioscler Thromb Vasc Biol 1995 15 : 2265 72.